NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
GREENCalcifediol 266 microgram capsules Domnisol® Nutrition and blood, Vitamin D, 09.06.04
REDLiraglutide Saxenda®
(6mg/ml Solution for injection in pre-filled pen) 		Central nervous system, Drugs used in the treatment of obesity, 04.05
GREENOrlistat  Central nervous system, Anti-obesity drugs acting on the gastro-intestingal tract, 04.05.01
REDSemaglutide Wegovy®
(0.25mg, 0.5mg, 1mg, 1.7mg & 2.4mg solution for injection in pre-filled pen) 		Central nervous system, Drugs used in the treatment of obesity, 04.05
REDTirzepatide Mounjaro®
(Overweight and obesity) 		Central nervous system, Drugs used in the treatment of obesity, 04.05
GREENTirzepatide solution for injection in pre-filled pen Mounjaro®
(Type 2 diabetes) 		Endocrine system, GLP-1 mimetics, 06.01.02.03
Non Formulary items found
Status Description Section
DNPNaltrexone/ bupropion Mysimba® Central nervous system, Anti-obesity drugs acting on the gastro-intestingal tract, 04.05.01
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Liraglutide Liraglutide Gastro-Intestinal System, Obesity, Blood Glucose Lowering Drugs Glucagon-Like Peptide-1 Receptor Agonists
Naltrexone Naltrexone With Bupropion Gastro-Intestinal System, Obesity
Naltrexone Naltrexone With Bupropion Gastro-Intestinal System, Obesity, Antidepressants Serotonin And Noradrenaline Re-Uptake Inhibitors
Orlistat Orlistat Gastro-Intestinal System, Obesity
Semaglutide Semaglutide Gastro-Intestinal System, Obesity, Blood Glucose Lowering Drugs Glucagon-Like Peptide-1 Receptor Agonists
SetmelanotideSetmelanotide Gastro-Intestinal System, Obesity
Tirzepatide Tirzepatide Gastro-Intestinal System, Obesity, Blood Glucose Lowering Drugs Blood Glucose Lowering Drugs, Other
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NHS England Interim Commissioning Guidance: Implementation of the NICE Technology Appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro®) for the management of obesity
NICE guideline [NG246]: Overweight and obesity management
NICE TA 664 Liraglutide for managing overweight and obesity
NICE TA1026: Tirzepatide for managing overweight and obesity
NICE TA494: Naltrexone–bupropion for managing overweight and obesity
NICE TA875: Semaglutide for managing overweight and obesity
Specialist Weight Management Obesity/Bariatric Service Referral Form